Effect of Disease Severity on the Quality of Life and Sense of Stigmatization in Psoriatics

Overview

Journal Clin Cosmet Investig Dermatol

Publisher Dove Medical Press

Specialty Dermatology

Date 2021 Feb 10

PMID 33564255

Citations 4

Authors

Beata Kowalewska

Barbara Jankowiak

Mateusz Cybulski

Elzbieta Krajewska-Kulak

Dzmitry Fiodaravich Khvorik

Affiliations

Soon will be listed here.

Abstract

Introduction: Psoriasis is a chronic inflammatory disease of the skin having a profound effect on the quality of life and contributing to the sense of stigmatization in the affected patients. The aim of this study was to analyze the effect of psoriasis severity on the quality of life and sense of stigmatization in psoriatics and to investigate relationships between these measures and sociodemographic variables.

Patients And Methods: The study included 111 patients with psoriasis. The inclusion criteria of the study were the diagnosis of psoriasis and written informed consent to participate. The study was based on a short survey prepared by the authors and four validated scales: Dermatology Life Quality Index (DLQI), 6-item Stigmatization Scale, 33-item Feelings of Stigmatization Questionnaire, and Psoriasis Area and Severity Index (PASI).

Results: Mean PASI score for the study group was 14 pts. Most respondents presented with low DLQI scores, with the mean value of 10.8 pts suggesting that the disease-related ailments were not extremely burdensome for the majority of the patients. Mean stigmatization scores for the 6- and 33-item scale were 7-8 and 81-82 pts, respectively.

Conclusion: The severity of psoriasis was the strongest determinant of the quality of life measured with the DLQI. Also, the levels of stigmatization determined with the 6- and 33-item scale correlated significantly with PASI scores.

Citing Articles

Quality of life among adults with scabies: A community-based cross-sectional study in north-western Ethiopia.

Yirgu R, Middleton J, Cassell J, Bremner S, Davey G, Fekadu A PLoS Negl Trop Dis. 2024; 18(8):e0012429.

PMID: 39163473 PMC: 11364464. DOI: 10.1371/journal.pntd.0012429.

Impact of Alcohol Consumption, Smoking, and Diet on the Severity of Plaque Psoriasis: A Comprehensive Assessment using Clinical Scales and Quality of Life Measures.

Michalski P, Palazzo-Michalska V, Michalska-Bankowska A, Bankowski M, Grabarek B Med Sci Monit. 2023; 29:e941255.

PMID: 37528577 PMC: 10405633. DOI: 10.12659/MSM.941255.

A Comparative Analysis of the Predictors, Extent and Impacts of Self-stigma in Patients with Psoriasis and Atopic Dermatitis.

Schlachter S, Sommer R, Augustin M, Tsianakas A, Westphal L Acta Derm Venereol. 2023; 103:adv3962.

PMID: 37014270 PMC: 10108622. DOI: 10.2340/actadv.v103.3962.

Stigmatization in Patients With Psoriasis: A Mini Review.

Zhang H, Yang Z, Tang K, Sun Q, Jin H Front Immunol. 2021; 12:715839.

PMID: 34867945 PMC: 8634029. DOI: 10.3389/fimmu.2021.715839.

References

Zieciak T, Rzepa T, Krol J, Zaba R . Stigmatization feelings and depression symptoms in psoriasis patients. Psychiatr Pol. 2018; 51(6):1153-1163. DOI: 10.12740/PP/68848. View

Vardy D, Besser A, Amir M, Gesthalter B, Biton A, Buskila D . Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients. Br J Dermatol. 2002; 147(4):736-42. DOI: 10.1046/j.1365-2133.2002.04899.x. View

Kowalewska B, Cybulski M, Jankowiak B, Krajewska-Kulak E . Acceptance of Illness, Satisfaction with Life, Sense of Stigmatization, and Quality of Life among People with Psoriasis: A Cross-Sectional Study. Dermatol Ther (Heidelb). 2020; 10(3):413-430. PMC: 7211781. DOI: 10.1007/s13555-020-00368-w. View

Al-Mazeedi K, El-Shazly M, Al-Ajmi H . Impact of psoriasis on quality of life in Kuwait. Int J Dermatol. 2006; 45(4):418-24. DOI: 10.1111/j.1365-4632.2006.02502.x. View

Zachariae R, Zachariae C, Ibsen H, Mortensen J, Wulf H . Dermatology life quality index: data from Danish inpatients and outpatients. Acta Derm Venereol. 2000; 80(4):272-6. DOI: 10.1080/000155500750012153. View

Gerdes S, Zahl V, Weichenthal M, Mrowietz U . Smoking and alcohol intake in severely affected patients with psoriasis in Germany. Dermatology. 2009; 220(1):38-43. DOI: 10.1159/000265557. View

van Beugen S, van Middendorp H, Ferwerda M, Smit J, Zeeuwen-Franssen M, Kroft E . Predictors of perceived stigmatization in patients with psoriasis. Br J Dermatol. 2016; 176(3):687-694. DOI: 10.1111/bjd.14875. View

Langley R, Krueger G, Griffiths C . Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis. 2005; 64 Suppl 2:ii18-23. PMC: 1766861. DOI: 10.1136/ard.2004.033217. View

Sampogna F, Chren M, Melchi C, Pasquini P, Tabolli S, Abeni D . Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis. Br J Dermatol. 2006; 154(2):325-31. DOI: 10.1111/j.1365-2133.2005.06909.x. View

10.

Petraskiene R, Valiukeviciene S, Macijauskiene J . Associations of the quality of life and psychoemotional state with sociodemographic factors in patients with psoriasis. Medicina (Kaunas). 2016; 52(4):238-243. DOI: 10.1016/j.medici.2016.07.001. View

11.

Fortune D, Richards H, Griffiths C . Psychologic factors in psoriasis: consequences, mechanisms, and interventions. Dermatol Clin. 2005; 23(4):681-94. DOI: 10.1016/j.det.2005.05.022. View

12.

Fortes C, Mastroeni S, Leffondre K, Sampogna F, Melchi F, Mazzotti E . Relationship between smoking and the clinical severity of psoriasis. Arch Dermatol. 2005; 141(12):1580-4. DOI: 10.1001/archderm.141.12.1580. View

13.

Finzi A, Colombo D, Caputo A, Andreassi L, Chimenti S, Vena G . Psychological distress and coping strategies in patients with psoriasis: the PSYCHAE Study. J Eur Acad Dermatol Venereol. 2007; 21(9):1161-9. DOI: 10.1111/j.1468-3083.2007.02079.x. View

14.

Hong J, Koo B, Koo J . The psychosocial and occupational impact of chronic skin disease. Dermatol Ther. 2008; 21(1):54-9. DOI: 10.1111/j.1529-8019.2008.00170.x. View

15.

Schmid-Ott G, Kunsebeck H, Jager B, Sittig U, Hofste N, Ott R . Significance of the stigmatization experience of psoriasis patients: a 1-year follow-up of the illness and its psychosocial consequences in men and women. Acta Derm Venereol. 2005; 85(1):27-32. DOI: 10.1080/000155550410021583. View

16.

Finlay A, Khan G . Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994; 19(3):210-6. DOI: 10.1111/j.1365-2230.1994.tb01167.x. View

17.

FREDRIKSSON T, Pettersson U . Severe psoriasis--oral therapy with a new retinoid. Dermatologica. 1978; 157(4):238-44. DOI: 10.1159/000250839. View

18.

Sendrasoa F, Razanakoto N, Ratovonjanahary V, Raharolahy O, Ranaivo I, Andrianarison M . Quality of Life in Patients with Psoriasis Seen in the Department of Dermatology, Antananarivo, Madagascar. Biomed Res Int. 2020; 2020:9292163. PMC: 7512037. DOI: 10.1155/2020/9292163. View

19.

Dauendorffer J, Ly S, Beylot-Barry M . Psoriasis and male sexuality. Ann Dermatol Venereol. 2019; 146(4):273-278. DOI: 10.1016/j.annder.2019.01.021. View

20.

Gupta M, Gupta A . Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management. Am J Clin Dermatol. 2003; 4(12):833-42. DOI: 10.2165/00128071-200304120-00003. View